Deep Track's new 5.64% passive stake, combined with ADAR1 Capital's 17.2% position, means over 22% of shares are held by two passive filers post-merger. Monitor for any future 13D conversion or additional insider buying, but the passive certification suggests no near-term activist intent.
Price Chart
How similar events traded
Executive Summary
Deep Track Capital, LP filed a Schedule 13G disclosing a 5.64% passive stake in Mentari Therapeutics (formerly InMed Pharmaceuticals) as of November 13, 2026, representing 2,977,478 common shares. This is a new position following the company's reverse merger with Mentari on November 6, 2026, and adds to the existing passive ownership by ADAR1 Capital (17.2%) and prior filer Ikarian Capital.
Key Financial Metrics
Key Facts
- Deep Track Capital, LP disclosed a 5.64% passive stake in Mentari Therapeutics (formerly InMed Pharmaceuticals) as of November 13, 2026
- The stake consists of 2,977,478 common shares, held across Deep Track Biotechnology Master Fund, Ltd. (2,214,135 shares) and Deep Track Special Opportunities Fund, LP (763,343 shares)
- The filing certifies passive intent under Rule 13d-1(c), with no purpose of changing or influencing control
- This is a new position filed 7 days after the company's reverse merger with Mentari on November 6, 2026
- The issuer reported 52,813,914 common shares outstanding as of November 10, 2026
- David Kroin is the control person for Deep Track Capital, LP
Financial Impact
5.64% passive stake valued at approximately $508K based on $9M market cap
Risk Factors
- Passive stake certification could be converted to active (13D) if Deep Track changes intent, though no indication in this filing
- Small market cap ($9M) and high volatility (10% normal daily move) make the stock susceptible to large price swings on low volume
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001172661-26-005030 |
| Document: 0001172661-26-005030-index.html | 0001172661-26-005030 |
| Document: 0001172661-26-005030.txt | 0001172661-26-005030 |
Track record
10 reports on MTRI
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $17.90 Now $19.87 −11.01% settles Dec 15
- Nov 16, 2026today 8-K Neutral 6/10 Entry $18.60 Now $19.87 +6.83% settles Dec 15
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $19.02 Now $19.87 +4.47% settles Dec 15
- Nov 13, 20263d ago SC 13G Neutral 4/10 Viewing Entry $15.75 Now $19.87 +26.16% settles Dec 15
- Nov 12, 20264d ago SC 13D Neutral 5/10 Entry $18.60 Now $19.87 +6.83% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $18.60 Now $19.87 +6.83% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $18.60 Now $19.87 +6.83% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $18.60 Now $19.87 +6.83% settles Dec 14
- Nov 10, 20266d ago 8-K Mixed 7/10 Entry $15.61 Now $19.87 +27.30% settles Dec 10
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $16.00 Now $19.87 +24.19% settles Dec 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers